← CVS HEALTH Corp

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
ASSETS
Current assets:
Cash and Cash Equivalents, at Carrying Value $3.4b $1.7b $4.1b $5.7b $7.9b $9.4b $12.9b $8.2b $8.6b $8.5b
Short-term Investments $87.0m $111.0m $2.5b $2.4b $3.0b $3.1b $2.8b $3.3b $2.4b $2.1b
Cash and cash equivalents $3.4b $1.7b $4.1b $5.7b $7.9b $9.4b $12.9b $8.2b $8.6b $8.5b
Accounts receivable, net $12.2b $13.2b $17.6b $19.6b $21.7b $24.4b $27.3b $35.2b $36.5b $39.8b
Other current assets $660.0m $945.0m $4.6b $5.1b $5.3b $5.3b $2.7b $3.2b $3.1b $5.1b
Inventory, Net $14.8b $15.3b $16.4b $17.5b $18.5b $17.8b $19.1b $18.0b $18.1b $19.2b
Assets, Current $31.0b $31.2b $45.2b $50.3b $56.4b $60.0b $65.7b $67.9b $68.6b $74.7b
Total current assets $31.0b $31.2b $45.2b $50.3b $56.4b $60.0b $65.7b $67.9b $68.6b $74.7b
Long-term investments — $112.0m $15.7b $17.3b $20.8b $23.0b $21.1b $23.0b $28.9b $32.7b
Property, Plant and Equipment, Net $10.2b $10.3b $11.3b $12.0b $12.6b $12.9b $12.9b $13.2b $13.0b $13.1b
Goodwill $38.2b $38.5b $78.7b $79.7b $79.6b $79.1b $78.2b $91.3b $91.3b $85.5b
Intangible Assets, Net (Excluding Goodwill) $13.5b $13.6b $36.5b $33.1b $31.1b $29.0b $24.8b $29.2b $27.3b $25.5b
Intangible assets, net $13.5b $13.6b $36.5b $33.1b $31.1b $29.0b $24.8b $29.2b $27.3b $25.5b
Operating Lease, Right-of-Use Asset — — — $20.9b $20.7b $19.1b $17.9b $17.3b $15.9b $15.0b
Other Assets, Noncurrent $1.5b $1.5b $5.0b $4.6b $4.6b $4.7b $4.6b $4.7b $4.8b $5.1b
Operating lease right-of-use assets — — — $20.9b $20.7b $19.1b $17.9b $17.3b $15.9b $15.0b
Other assets $1.5b $1.5b $5.0b $4.6b $4.6b $4.7b $4.6b $4.7b $4.8b $5.1b
Additional Financial Items
Accounts Receivable, after Allowance for Credit Loss, Current $12.2b $13.2b $17.6b $19.6b $21.7b $24.4b $27.3b $35.2b $36.5b $39.8b
Investments $87.0m $111.0m $2.5b $2.4b $3.0b $3.1b $2.8b $3.3b $2.4b $2.1b
Separate accounts assets — $0 $3.9b $4.5b $4.9b $5.1b $3.2b $3.2b $3.3b $2.0b
Pharmacy claims and discounts payable — $10.4b $12.3b $13.6b $15.8b $17.3b $19.4b $22.9b $24.2b $26.3b
Health care costs payable — $5.0m $5.2b $6.9b $7.9b $8.8b $10.4b $12.0b $15.1b $15.4b
Accrued expenses and other current liabilities $6.9b $6.6b $10.7b $12.1b $14.2b $17.7b $18.7b $22.2b $20.8b $22.4b
Other insurance liabilities — $23.0m $1.9b $1.8b $1.6b $1.3b $1.1b $1.1b $1.2b $1.1b
Current portion of operating lease liabilities — — — $1.6b $1.6b $1.6b $1.7b $1.7b $1.8b $1.7b
Long-term operating lease liabilities — — — $18.9b $18.8b $18.2b $16.8b $16.0b $14.9b $13.6b
Deferred income taxes $4.2b $3.0b $7.7b $7.3b $6.8b $6.3b $3.9b $4.3b $3.8b $3.8b
Separate accounts liabilities — $0 $3.9b $4.5b $4.9b $5.1b $3.2b $3.2b $3.3b $2.0b
Other long-term insurance liabilities — $334.0m $8.1b $7.4b $7.0b $6.4b $6.1b $5.5b $4.9b $4.7b
Accrued Liabilities, Current $6.9b $6.6b $10.7b $12.1b $14.2b $17.7b $18.7b $22.2b $20.8b $22.4b
Total CVS Health shareholders’ equity $36.8b $37.7b $58.2b $63.9b $69.4b $75.1b $71.0b $76.5b $75.6b $75.2b
Total shareholders’ equity $36.8b $37.7b $58.5b $64.2b $69.7b $75.4b $71.3b $76.6b $75.7b $75.4b
Assets $94.5b $95.1b $196.5b $222.4b $230.7b $233.0b $228.3b $249.7b $253.2b $253.5b
Total assets $94.5b $95.1b $196.5b $222.4b $230.7b $233.0b $228.3b $249.7b $253.2b $253.5b
LIABILITIES AND EQUITY
Current liabilities:
Operating Lease, Liability, Current — — — $1.6b $1.6b $1.6b $1.7b $1.7b $1.8b $1.7b
Accounts Payable, Current $7.9b $8.9b $8.9b $10.5b $11.1b $12.5b $14.8b $14.9b $15.9b $17.6b
Long-term Debt, Current Maturities $42.0m $3.5b $1.3b $3.8b $5.4b $4.2b $1.8b $2.8b $3.6b $4.1b
Operating Lease, Liability, Noncurrent — — $269.0m $18.9b $18.8b $18.2b $16.8b $16.0b $14.9b $13.6b
Long-term Debt, Excluding Current Maturities $25.6b $22.2b $71.4b $64.7b $59.2b $52.0b $50.5b $58.6b $60.5b $60.5b
Short-term debt $1.9b $1.3b $720.0m $0 — — $0 $200.0m $2.1b $0
Liabilities, Current $26.2b $30.6b $44.0b $53.3b $62.0b $67.8b $69.7b $79.2b $84.6b $88.7b
Total current liabilities $26.2b $30.6b $44.0b $53.3b $62.0b $67.8b $69.7b $79.2b $84.6b $88.7b
Deferred Income Tax Liabilities, Net — — $7.7b $7.3b $6.8b $6.3b $3.9b $4.3b $3.8b $3.8b
Other Liabilities, Noncurrent $1.5b $1.6b $2.8b $2.2b $2.4b $1.9b $6.7b $6.2b $5.4b $4.8b
Other long-term liabilities $1.5b $1.6b $2.8b $2.2b $2.4b $1.9b $6.7b $6.2b $5.4b $4.8b
Deferred Tax Liabilities, Net $4.2b $3.0b $7.7b $7.3b $6.8b $6.3b $3.7b $4.3b $3.8b $3.8b
Liabilities — — $137.9b $158.3b $161.0b $157.6b $157.0b $173.1b $177.5b $178.2b
Total liabilities — $57.4b $137.9b $158.3b $161.0b $157.6b $157.0b $173.1b $177.5b $178.2b
Commitments and Contingencies $0 — — — — — — — — —
Redeemable Noncontrolling Interest, Equity, Carrying Amount $0 — — — — — — — — —
Stockholders’ equity:
Preferred Stock, Value, Issued $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Common Stock, Value, Issued $17.0m $17.0m $17.0m $17.0m $17.0m $17.0m $18.0m $18.0m $18.0m —
Additional Paid in Capital $31.6b $32.1b — — — — — — — —
Retained Earnings (Accumulated Deficit) $39.0b $43.6b $40.9b $45.1b $49.6b $54.9b $56.1b $61.6b $62.8b $61.2b
Accumulated Other Comprehensive Income (Loss), Net of Tax ($305.0m) ($165.0m) $102.0m $1.0b $1.4b $965.0m ($1.5b) ($297.0m) ($120.0m) $406.0m
Treasury Stock, Common, Value — $32.1b $45.4b $46.0b $46.5b $47.4b $48.2b $33.8b $36.8b $36.8b
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding 0 0 0 0 0 0 0 0 0 0
Common stock, par value $0.01: 3,200 shares authorized; 1,787 shares issued and 1,271 shares outstanding at December 31, 2025 and 1,778 shares issued and 1,260 shares outstanding at December 31, 2024 and capital surplus — 32.1b 45.4b 46.0b 46.5b 47.4b 48.2b 49.0b 49.7b 50.4b
Treasury stock, at cost: 516 and 518 shares at December 31, 2025 and 2024 — — — — — — ($31.9b) ($33.8b) ($36.8b) ($36.8b)
Accumulated other comprehensive income (loss) ($305.0m) ($165.0m) $102.0m $1.0b $1.4b $965.0m ($1.5b) ($297.0m) ($120.0m) $406.0m
Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax $173.0m $21.0m $102.0m — — $965.0m — ($297.0m) ($120.0m) $406.0m
Stockholders' Equity Attributable to Parent $36.8b $37.7b $58.2b $63.9b $69.4b $75.1b $71.0b $76.5b $75.6b $75.2b
Stockholders' Equity Attributable to Noncontrolling Interest $4.0m $4.0m $318.0m $306.0m $312.0m $306.0m $300.0m $175.0m $170.0m $168.0m
Noncontrolling interests $4.0m $4.0m $318.0m $306.0m $312.0m $306.0m $300.0m $175.0m $170.0m $168.0m
Liabilities and Equity $94.5b $95.1b $196.5b $222.4b $230.7b $233.0b $228.3b $249.7b $253.2b $253.5b
Total liabilities and shareholders’ equity $94.5b $95.1b $196.5b $222.4b $230.7b $233.0b $228.3b $249.7b $253.2b $253.5b

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.